Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,106 JPY | +0.38% | +1.06% | -2.99% |
2023 | HABA Laboratories,Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
2021 | HABA Laboratories,Inc.(JASDAQ:4925) dropped from S&P Global BMI Index | CI |
Sales 2022 | 12.91B 82.17M | Sales 2023 | 12.04B 76.63M | Capitalization | 8.81B 56.09M |
---|---|---|---|---|---|
Net income 2022 | -269M -1.71M | Net income 2023 | -707M -4.5M | EV / Sales 2022 | 0.39 x |
Net cash position 2022 | 3.09B 19.7M | Net cash position 2023 | 2.78B 17.73M | EV / Sales 2023 | 0.5 x |
P/E ratio 2022 |
-30.4
x | P/E ratio 2023 |
-12.5
x | Employees | 654 |
Yield 2022 |
1.85% | Yield 2023 |
1.72% | Free-Float | 56.05% |
1 day | +0.38% | ||
1 week | +1.06% | ||
Current month | +4.62% | ||
1 month | +4.62% | ||
3 months | +1.25% | ||
6 months | -6.94% | ||
Current year | -2.99% |
Managers | Title | Age | Since |
---|---|---|---|
Issei Miyazaki
CEO | Chief Executive Officer | 61 | 13-09-30 |
Noriko Koyanagi
CHM | Chairman | 78 | 15-05-31 |
Chief Tech/Sci/R&D Officer | 59 | 20-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tsunekazu Umeda
BRD | Director/Board Member | 78 | 00-05-31 |
Noriko Koyanagi
CHM | Chairman | 78 | 15-05-31 |
Issei Miyazaki
CEO | Chief Executive Officer | 61 | 13-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-29 | 2,106 | +0.38% | 4 200 |
24-05-28 | 2,098 | +0.38% | 1,900 |
24-05-27 | 2,090 | 0.00% | 1,300 |
24-05-24 | 2,090 | +0.58% | 700 |
24-05-23 | 2,078 | -0.29% | 2,100 |
Delayed Quote Japan Exchange, May 29, 2024 at 02:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-2.99% | 50.55M | |
-1.61% | 259B | |
+18.81% | 20.66B | |
0.00% | 19.04B | |
+17.33% | 12.68B | |
-13.77% | 9.25B | |
+23.03% | 8.07B | |
+11.07% | 6.01B | |
-12.20% | 3.98B | |
-16.08% | 3.87B |
- Stock Market
- Equities
- 4925 Stock